Projected Earnings Date: 2025-10-30    (Delayed quote data   2025-09-12)
Last
 32.18
Change
 ⇓ -1.35   (-4.03%)
Volume
  818,624
Open
 33.35
High
 33.38
Low
 31.72
8EMA (Daily)
 33.15
40EMA (Daily)
 35.99
50EMA (Daily)
 36.63
STO (Daily)
 20.460
MACD Hist (Daily)
 -0.361
8EMA (Weekly)
 35.711
40EMA (Weekly)
 42.08
50EMA (Weekly)
 42.80
STO (Weekly)
 20.084
MACD Hist (Weekly)
 -0.863
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company dedicated to the identification, development, and commercialization of innovative therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. Vericel has marketed products and the goal is to become the leader in cell therapy and regenerative medicine by developing, manufacturing and marketing best-in-class therapies for patients with significant unmet medical needs. The Company operates in one reportable segment: the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com